486 related articles for article (PubMed ID: 35171030)
41. Characterization and in vitro activity of a lytic phage RDN37 isolated from community sewage water active against MDR Uropathogenic E. coli.
Chaudhary N; Narayan C; Mohan B; Taneja N
Indian J Med Microbiol; 2021 Jul; 39(3):343-348. PubMed ID: 33994226
[TBL] [Abstract][Full Text] [Related]
42. A Novel Phage Cocktail Therapy of the Urinary Tract Infection in a Mouse Model.
Mijbel Ali B; Gatea Kaabi SA; Al-Bayati MA; Musafer HK
Arch Razi Inst; 2021 Nov; 76(5):1229-1236. PubMed ID: 35355758
[No Abstract] [Full Text] [Related]
43. Ciprofloxacin resistance in uropathogenic Escherichia coli isolates causing community-acquired urinary infections in Brasília, Brazil.
Moreira da Silva RCR; de Oliveira Martins Júnior P; Gonçalves LF; de Paulo Martins V; de Melo ABF; Pitondo-Silva A; de Campos TA
J Glob Antimicrob Resist; 2017 Jun; 9():61-67. PubMed ID: 28419868
[TBL] [Abstract][Full Text] [Related]
44. Characterization of a newly isolated phage infecting pathogenic Escherichia coli and analysis of its mosaic structural genes.
Peng Q; Yuan Y
Sci Rep; 2018 May; 8(1):8086. PubMed ID: 29795390
[TBL] [Abstract][Full Text] [Related]
45. Therapeutics and prophylactic efficacy of novel lytic Escherichia phage vB_EcoS_PJ16 against multidrug-resistant avian pathogenic E. coli using in vivo study.
Jhandai P; Mittal D; Gupta R; Kumar M; Khurana R
Int Microbiol; 2024 Jun; 27(3):673-687. PubMed ID: 37632591
[TBL] [Abstract][Full Text] [Related]
46. Managing urinary tract infections through phage therapy: a novel approach.
Malik S; Sidhu PK; Rana JS; Nehra K
Folia Microbiol (Praha); 2020 Apr; 65(2):217-231. PubMed ID: 31494814
[TBL] [Abstract][Full Text] [Related]
47. Isolation and characterization of novel lytic bacteriophages that infect multi drug resistant clinical strains of Escherichia coli.
Padmesh S; Singh A; Chopra S; Sen M; Habib S; Shrivastava D; Johri P
Environ Sci Pollut Res Int; 2023 Jun; ():. PubMed ID: 37347328
[TBL] [Abstract][Full Text] [Related]
48. Presence of putative repeat-in-toxin gene tosA in Escherichia coli predicts successful colonization of the urinary tract.
Vigil PD; Stapleton AE; Johnson JR; Hooton TM; Hodges AP; He Y; Mobley HL
mBio; 2011; 2(3):e00066-11. PubMed ID: 21540363
[TBL] [Abstract][Full Text] [Related]
49. Isolation, characterization and in vivo efficacy of Escherichia phage myPSH1131.
Manohar P; Tamhankar AJ; Lundborg CS; Ramesh N
PLoS One; 2018; 13(10):e0206278. PubMed ID: 30356310
[TBL] [Abstract][Full Text] [Related]
50. Isolation and Characterization of a Novel Phage Collection against Avian-Pathogenic
Nicolas M; Trotereau A; Culot A; Moodley A; Atterbury R; Wagemans J; Lavigne R; Velge P; Schouler C
Microbiol Spectr; 2023 Jun; 11(3):e0429622. PubMed ID: 37140373
[TBL] [Abstract][Full Text] [Related]
51. Characterization of Lytic Bacteriophages Infecting Multidrug-Resistant Shiga Toxigenic Atypical
Montso PK; Mlambo V; Ateba CN
Front Public Health; 2019; 7():355. PubMed ID: 32039126
[TBL] [Abstract][Full Text] [Related]
52. Virulence genes and phylogenetic groups of uropathogenic Escherichia coli isolates from patients with urinary tract infection and uninfected control subjects: a case-control study.
Rezatofighi SE; Mirzarazi M; Salehi M
BMC Infect Dis; 2021 Apr; 21(1):361. PubMed ID: 33865334
[TBL] [Abstract][Full Text] [Related]
53. Shigella Phages Isolated during a Dysentery Outbreak Reveal Uncommon Structures and Broad Species Diversity.
Doore SM; Schrad JR; Dean WF; Dover JA; Parent KN
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437962
[TBL] [Abstract][Full Text] [Related]
54. Phenotypic Assessment of Clinical Escherichia coli Isolates as an Indicator for Uropathogenic Potential.
Shea AE; Frick-Cheng AE; Smith SN; Mobley HLT
mSystems; 2022 Dec; 7(6):e0082722. PubMed ID: 36445110
[TBL] [Abstract][Full Text] [Related]
55. Distribution of virulence genes and their association with antimicrobial resistance among uropathogenic Escherichia coli isolates from Iranian patients.
Malekzadegan Y; Khashei R; Sedigh Ebrahim-Saraie H; Jahanabadi Z
BMC Infect Dis; 2018 Nov; 18(1):572. PubMed ID: 30442101
[TBL] [Abstract][Full Text] [Related]
56. Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli.
Asadi Karam MR; Habibi M; Bouzari S
Mol Immunol; 2019 Apr; 108():56-67. PubMed ID: 30784763
[TBL] [Abstract][Full Text] [Related]
57. Characterization of virulence factors and antibiotic resistance pattern of uropathogenic
Kumar M N; Bhat S; Bhat K A; Saralaya V; Shenoy Mulki S
F1000Res; 2022; 11():1163. PubMed ID: 36531258
[No Abstract] [Full Text] [Related]
58. The Antibacterial Effects of Cocktail and Single Forms of Lytic Phages Belonging to
Jokar J; Rahimian N; Ghasemian A; Najafipour S
Biomed Res Int; 2022; 2022():7833565. PubMed ID: 36467878
[TBL] [Abstract][Full Text] [Related]
59. Virulence behavior of uropathogenic Escherichia coli strains in the host model Caenorhabditis elegans.
Schifano E; Marazzato M; Ammendolia MG; Zanni E; Ricci M; Comanducci A; Goldoni P; Conte MP; Uccelletti D; Longhi C
Microbiologyopen; 2019 Jun; 8(6):e00756. PubMed ID: 30381890
[TBL] [Abstract][Full Text] [Related]
60. Multi-drug resistant uropathogenic Escherichia coli and its treatment by Chinese medicine.
Liu SW; Xu XY; Xu J; Yuan JY; Wu WK; Zhang N; Chen ZL
Chin J Integr Med; 2017 Oct; 23(10):763-769. PubMed ID: 28028717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
